Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PregVit-Folic 5
- Development stage
- Discontinued
- Lead developer
- Duchesnay
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
PregVit-Folic 5 is a prescription-only prenatal multivitamin and mineral supplement developed by Duchesnay Inc. It is specifically formulated for women at an elevated risk of neural tube defect (NTD)-affected pregnancies, such as those with a personal or family history of NTDs, diabetes, or malabsorption issues. The product consists of a two-tablet regimen: a pink morning tablet containing iron, zinc, and various vitamins, and a blue evening tablet containing 5 mg of folic acid, vitamin B12, vitamin D3, and calcium. This split-dose formulation is designed to optimize the absorption of nutrients like iron and calcium, which can interfere with each other when taken simultaneously. The high-dose folic acid (5 mg) targets the folate metabolic pathway to reduce the risk of congenital malformations. It was marketed in Canada but was cancelled post-market as of March 31, 2025.
- Brand names
- PregVit-Folic 5PregVit-Folic5PregVit-Folic-5Pregvit Folic 5
- Other names
- PregVit Folic 5
02
Targets
SLC46A1 (Proton-coupled folate transporter)FOLR1 (FRα)VDR (Vitamin D receptor)RFC1 (Reduced folate carrier type 1)FOLR2 (Folate receptor beta)
Beyond the preview
Go deeper on PregVit-Folic 5.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PregVit-Folic 5.